¥1,768.50
0.88%
Tokyo, Oct 05, 01:51 pm JST. Market open.
ISIN
JP3435750009
Symbol
2413
Index

M3 Stock price

¥1,753.00
-29.50 1.66% 1M
+111.50 6.79% 6M
-361.00 17.08% YTD
-447.00 20.32% 1Y
-916.00 34.32% 3Y
-5,836.00 76.90% 5Y
-19.50 1.10% 10Y
+1,592.17 989.95% 20Y
Tokyo, Closing price Fri, Oct 02 2026
-46.00 2.56%
ISIN
JP3435750009
Symbol
2413
Index

AI Insights on M3 Insights AI Insights on M3

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is M3 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
¥1.2t
Enterprise Value
¥1.1t
Net debt
-
Cash
-
Shares outstanding
-
Valuation
P/E
25.3
P/S | estimate
3.4 | 3.1
EV/Sales | estimate
3.1 | 2.8
EV/FCF | ex SBC
18.8 | -
P/B
3.0
Dividends
DPS
¥21.00
Yield 1Y | 5Y
1.2% | 0.4%
Growth 1Y | 5Y
0.0% | 19.8%
Payout 1Y | 3Y
35.2% | 30.7%
Increased
0 Years
Financials
Revenue | estimate
¥355.3b | ¥395.8b
EBITDA
-
EBIT
¥68.9b
Net Income
¥46.3b
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
15.8% | 12.6%
EBITDA
-
EBIT
9.4%
Net Income
12.8%
Free Cash Flow
-
Margin
Gross
49.5%
EBITDA
-
EBIT
19.4%
Net
13.0%
Free Cash Flow | ex SBC
- | -
Financial Health
Equity Ratio
64.0%
Return on Equity
12.0%
ROCE
12.8%
ROIC
12.1%
Debt/Equity
-
More
EPS
¥69.4
FCF per Share
-
Short interest
-
Employees
15k
Rev per Employee
¥22.9m

M3 Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a M3 forecast:

10x Buy
59%
7x Hold
41%

Analyst Opinions

17 Analysts have issued a M3 forecast:

Buy
59%
Hold
41%

Financial data from M3

Jun '26
+/-
%
355,268 355,268
16% 16%
100%
- Direct Costs 179,540 179,540
24% 24%
51%
175,728 175,728
9% 9%
49%
- Selling and Administrative Expenses 107,489 107,489
10% 10%
30%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 68,884 68,884
9% 9%
19%
Net Profit 46,334 46,334
13% 13%
13%

In millions JPY.

Don't miss a Thing! We will send you all news about M3 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Portal, Evidence Solutions, Overseas, Clinical Platform, and Others. The Medical Portal segment provides the medical-related marketing support and research services. The Evidence Solutions segment includes clinical research support business, medical clinical trials management, and management support business. The Overseas segment offers marketing support and research services for medical-related firms in the United States, the United Kingdom, and South Korea. The Clinical Platform segment engages in the development, sale and support of electronic medical records. The Others segment offers information services for medical institutions and prescription drug advertising business. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Itaru Tanimura
Employees 15,360
Founded 2000
Website corporate.m3.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today